Pharmacology of gut microbiome Flashcards

1
Q

what is the gut microbiome

A

the gut microbiome is the collective genome in the gut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

give two possible reasons for reduced gut microbiota diversity

A

dietary fibre-deficient diet and antibiotic use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is fecal microbial transplantation?

A

transfer o complex incompletely defined community of micro-organisms from a healthy donor (screened for the absence of pathogens) to a recipient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

the production of which metabolites can result from FMTT?

A

short-chain fatty acids and secondary bile acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what clinical scenario is FMT currently used in?

A

clostridioides difficile colitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what type of bacteria is c. diff?

A

an obligate anaerobic non-spore forming bacteria that produces a toxin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what was the initial treatment of c. diff colitits?

A

antibiotic treatment; high failure rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what was the success rate of FMT from healthy donors to c. diff colitis patients?

A

90% success rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is acredited with FMT-related successful treatment of c. diff colitis?

A

the engraftment (establishment of replicating self-sustaining species) of donor symbiotic strains in the recipient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is Rebyota?

A

FDA approved CDI treatment in patients aged 18+.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what were the most common symptoms associated with CDI?

A

abdominal pain, diarrhea, abdominal distension, flatulence and nausea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why was there more success with FMT in CDI than in UC?

A

In CDI, there is complete loss of microbiota, whereas in UC, would need bacteria already-present to adapt.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what obstacle has limited clinical use of FMT?

A

The inability to define donor samples’ exact composition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the five major phyla in gut?

A

bacteriodetes, firmicutes, verrucomicrobia, actinobacteria, and proteobacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

plant-based diet increases the prevalence of which phylum in the gut?

A

plant based diet increases the prevalence of firmicutes in the gut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

name two example species of firmicutes?

A

lactobacillales and clostridiales

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

give three functions of clostridiales?

A

resist pathogenic colonization, ameliorate IBD, and promote T cell differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

name two metabolites that clostridiales produce?

A

clostridiales produce butyrate and secondary bile acids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how do lactobacillales impact the gut

A

lactobacillales interact with the gut epithelium to produce antimicrobial peptides, promote mucosal homeostasis and metabolise tryptophan to produce bioactive compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

bacteriodetes comprise _ - _% of our colonic microbiota and this range is largely impacted by?

A

bacteriodetes comprise 5-60% of our colonic microbiota and this range is largely impacted by diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

which phyla can metabolise complex polysaccarides and how do they acheive this?

A

bacteriodetes can metabolise complex polysaccarides due to 25% of their genome encoding polysaccaride utilising loci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is polysaccaride utilising loci

A

this loci is dedicated to polysaccaride import and degradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what phylum is associated with enhanced response to immune checkpoint inhibitors?

A

verruccomicrobia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is the predominant microbe in infant gut (ideally)?

A

bifidobacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what does bifidobacterium provide resistance to and how does it achieve this?

A

bifidobacterium strains expressing AC transporters which support acetate production which enhances resistance to enterohemorrhagic e coli

26
Q

what immune cell does bifidobacterium breve stimulate?

A

bifidobacterium breve stmulates T regs in the colon

27
Q

bifido strains and checkpoint inhibitors that have shown enhanced response to the checkpoint inhibitors?

A

b. breve and b. longum, PDL-1 inhibitor

28
Q

what is a probiotic

A

live micro-organisms when administered in adequate amounts confer a health benefit to the host

29
Q

what is a prebiotic?

A

a substrate that is selectively utilised by host micro-organisms conferring a health benefit

30
Q

name the four categories of microbiome-based therapeutics? (besides FMT)

A

Diet and probiotics, symbiotic-microbial consertia, engineered symbiotic bacteria, and microbiota derived metabolites and proteins

31
Q

name dietary and probiotic interventions

A

dietary fiber, complex polysaccharides, fermented foods

32
Q

what needs to be present for prebiotics to be effective?

A

symbiotic bacterial strains need to be present for prebiotic efficacy as this is essentially ‘feeding’ already-present microbes

33
Q

what is microbial consortia?

A

transfer of bacterial isolates (selected or defined) to promote specific-microbiota function

34
Q

what is the aim of symbiotic microbia consortia?

A

to establish well-characterised bacterial strains that behave in harmony and synergise functional responses that can re-establish microbiota compositions and may provide health benefits

35
Q

what is the primary impact of a diverse microbiota?

A

resistance to colonistaion and inhibit enteric pathogenic bacteria growth.

36
Q

consortia including which phylum inhibited colonisation with salmonella typhimurium?

A

consortia with propionate-producing bacteriodetes is assoicated with s. typhimurium resistance.

37
Q

what loci can be engineered into bacterial strains to enhance colonisation resistance?

A

polysaccharide utilisation locus can be engineered into recombinant strains to provide a selective advantage over other bacterial populations as well as enhance colonisation resistance

38
Q

genes derived from c. scindens are incoporated into c. sporagenes to enable what in the recombinant bacteria?

A

genes in c. scindens involved in the conversion of primary bile acids to secondary bile acids are engineered into c. sporogenes to enable recombinant bacteria to synthesise deoxycholic acid and lithocholic acid

39
Q

what genetic engineering tool can be used to eliminate pathogenic traits of a recombinant bacteria?

A

CRISPR-cass9

40
Q

name two things often reduced or even completely depleted following antibiotic treatment?

A

SCFA and secondary bile acids

41
Q

what receptor family can microbiota derived metabolites bind?

A

GPCRs can be activated by microbiota derived metabolites

42
Q

in which population are microbiota derived proteins and metabolites ideal for?

A

in the immunocompromised

43
Q

what are some problems associate with microbiota derived proteins and metabolites?

A

production, adequate drug delivery to intended GIT site, impact influenced by absorptive capacity and systemic dissemmination versus function in the gut lumen

44
Q

name the three most abundant SCFA in the gut?

A

acetate, propionate, butyrate

45
Q

what are SCFAs involved in the mediation of?

A

SCFAs are involved in the mediation of immunoregulation, colonisation resistance, and protection from LRT viral infection

46
Q

describe the conversion of primary bile acids to secondary bile acids

A

primary bile acids, 5% of which enter the LI.
bile salt hydrolases (BSHs) remove a lycine or taurine to yield cholate or chenodeoxycholate. cholate and chenodeoxycholate are further metabolized by 7alpha-hydroxylation to produce secondary bile acids deoxycholic acid and lithocholic acid

47
Q

what can varying BSH and 7alpha hydroxylase activity affcet?

A

T cell differentiation (Th17 and TRegs)

48
Q

what are psychobiotics?

A

these are live micro-organisms that when ingested in adequate amounts they produce a health benefit in patients suffering with psychiatric illness

49
Q

metabolism of which amino acid do psychobiotics typically target?

A

tryptophan metabolism - directly involved in supply for serotonin and kyneurenine production

50
Q

where can propionate improve barrier integrity?

A

in the BBB

51
Q

What two reactions are the primary chemical mechanisms of gut microbiota drug metabolism?

A

reductive and hydrolytic reactions are the primary reactions in gut microbiota metabolism of drugs

52
Q

what is digoxin and what are its uses?

A

digoxin is a cardiac glycoside used to treat heart failure and atrial fibrillation

53
Q

what happens in digoxin metabolism in 10% of patients?

A

in 10% patients, digoxin is converted to inactive metabolite as the result of reduction reaction

54
Q

what prevents the metabolism of digoxin to an inactive metabolite?

A

arginine, hence high arginine diet reccomended for digoxin

55
Q

what bacteria has an operon that is activated by digoxin and causes cardiac inactiivty

A

eggerthelia lenta has a cardiac glycoside reductase operon which is activated by digoxin

56
Q

campothecan-11 metabolite?

A

SN-38 (by carboxylesterases)

57
Q

what enzyme converts SN-38G to SN-38

A

bacterial beta-glucuronidase reactivates SN-38G to SN-38 (toxic)

58
Q

what is meslamine - 5 Amino salicylic acid used to treat

A

IBD

59
Q

how is up to 1/3 of 5-ASA metabolised?

A

acetylation by enzymes encoded by gut bacteria, specifically salmonella strains, convert 5-ASA to N-Acetyl 5-ASA

60
Q

why is the formation of N-Acetyl 5-ASA unfavorable?

A

N-Acetyl 5-ASA lacks anti-inflammatory capacity and renders the treatment ineffective